Reliability and validity of a symptom management scale in a sample of Chinese treatment seekers

Introduction The Recovery Assessment Scale-Domains and Stages (RAS-DS) is a recently developed measure that builds on the original Recovery Assessment Scale (RAS). Within the RAS-DS, which measures one’s recovery from mental illness, a specific domain is called “Clinical Recovery” (RAS-DS-CR). It extends the “Not Dominated by Symptoms” subscale of the original RAS, which only has three items. The RAS-DS-CR provides a more comprehensive assessment of the sense of control over symptoms and is a promising, easily-administered outcome measure for evaluating early interventions such as psychoeducation and skills training programs. Objectives This study examined the psychometric properties of the 7-item RAS-DS-CR in a Chinese sample of treatment seekers. Methods We analyzed data from 91 participants from a two-month psychoeducation program (M age = 28.87; SD = 7.84, 89.0% female). At baseline, they exhibited high levels of post-traumatic (mean PCL-5 = 57.18; SD = 14.68) and dissociative (mean DES-T = 47.90; SD = 23.13) symptoms. All participants completed the baseline assessment, 83 completed the 2 nd pretest, 58 completed the posttest, and 44 completed the two-month follow-up test. They completed the RAS-DS-CR and other validated self-report measures at each time point. Results The RAS-DS-CR revealed good internal consistency (α = .805 to .871) at each time point. Intraclass correlations of two tests taken pre-intervention (ICC = .524, p <.001) and post-intervention (ICC = .613, p <.001) indicated moderate test-retest reliability. At each time point, the RAS-DS-CR was significantly correlated with self-esteem (r = .338 to .574), depressive symptoms (r = -.402 to -.486), and PTSD symptoms (r = -.245 to -.462), indicating its construct validity. The paired sample t-test also suggested that participants scored significantly higher on the RAS-DS-CR post-intervention compared to pre-intervention (t = -4.330, p < .001; Cohen’s d = 0.56), providing evidence for its sensitivity to change. Conclusions This study provided new evidence for the reliability and validity of the RAS-DS-CR. The RAS-DS-CR is a short and easy-to-use outcome measure of one’s mental health recovery in terms of the confidence in symptom management. Disclosure of Interest None Declared

Authors

Institutions

Publication Details

Journal
European Psychiatry
Published
2025-04-01
DOI
https://doi.org/10.1192/j.eurpsy.2025.1585
Primary Topic
Resilience and Mental Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reliability and validity of a symptom management scale in a sample of Chinese treatment seekers

Jonathan W.C. Wong, Anson Kai Chun Chau, Hoki Fung, Chin-Hua Huang et al.
European Psychiatry
Resilience and Mental Health
article

Reliability and validity of a symptom management scale in a sample of Chinese treatment seekers

Jonathan W.C. Wong, Anson Kai Chun Chau, Hoki Fung, Chin-Hua Huang, S. K. K. Lam, T. Y. N. Tsui
article en

Abstract

Introduction The Recovery Assessment Scale-Domains and Stages (RAS-DS) is a recently developed measure that builds on the original Recovery Assessment Scale (RAS). Within the RAS-DS, which measures one’s recovery from mental illness, a specific domain is called “Clinical Recovery” (RAS-DS-CR). It extends the “Not Dominated by Symptoms” subscale of the original RAS, which only has three items. The RAS-DS-CR provides a more comprehensive assessment of the sense of control over symptoms and is a promising, easily-administered outcome measure for evaluating early interventions such as psychoeducation and skills training programs. Objectives This study examined the psychometric properties of the 7-item RAS-DS-CR in a Chinese sample of treatment seekers. Methods We analyzed data from 91 participants from a two-month psychoeducation program (M age = 28.87; SD = 7.84, 89.0% female). At baseline, they exhibited high levels of post-traumatic (mean PCL-5 = 57.18; SD = 14.68) and dissociative (mean DES-T = 47.90; SD = 23.13) symptoms. All participants completed the baseline assessment, 83 completed the 2 nd pretest, 58 completed the posttest, and 44 completed the two-month follow-up test. They completed the RAS-DS-CR and other validated self-report measures at each time point. Results The RAS-DS-CR revealed good internal consistency (α = .805 to .871) at each time point. Intraclass correlations of two tests taken pre-intervention (ICC = .524, p <.001) and post-intervention (ICC = .613, p <.001) indicated moderate test-retest reliability. At each time point, the RAS-DS-CR was significantly correlated with self-esteem (r = .338 to .574), depressive symptoms (r = -.402 to -.486), and PTSD symptoms (r = -.245 to -.462), indicating its construct validity. The paired sample t-test also suggested that participants scored significantly higher on the RAS-DS-CR post-intervention compared to pre-intervention (t = -4.330, p < .001; Cohen’s d = 0.56), providing evidence for its sensitivity to change. Conclusions This study provided new evidence for the reliability and validity of the RAS-DS-CR. The RAS-DS-CR is a short and easy-to-use outcome measure of one’s mental health recovery in terms of the confidence in symptom management. Disclosure of Interest None Declared

European PsychiatryVol. 68(S1)
Chinese University of Hong Kong (HK), Australian Catholic University (AU), University of Hong Kong (HK)
Openalex Percentile: Top 66%
Resilience and Mental Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.